Contrast-enhanced US with Perfluorobutane to Diagnose Small Lateral Cervical Lymph Node Metastases of Papillary Thyroid Carcinoma. 2023

Lingli Xiao, and Jianhua Zhou, and Wen Tan, and Ying Liu, and Haoming Zheng, and Guanying Wang, and Wei Zheng, and Xiaoqing Pei, and Ankui Yang, and Longzhong Liu
From the Departments of Ultrasound (L.X., J.Z., H.Z., G.W., W.Z., X.P., L.L.) and Head and Neck Surgery (A.Y.), Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou 510060, PR China; and Department of Ultrasound, Sun Yat-sen University, Affiliated Hospital 8, Shenzhen, PR China (W.T., Y.L.).

Background Although metastasis of lateral cervical lymph nodes (LNs) is common in papillary thyroid carcinoma (PTC), correctly diagnosing small metastatic LNs with US remains challenging. The use of contrast-enhanced US (CEUS), especially the postvascular phase of CEUS with perfluorobutane contrast material, might contribute to improved diagnosis of metastatic LNs in PTC. Purpose To assess the diagnostic value of the postvascular phase of CEUS with perfluorobutane in suspicious small lateral cervical LNs (short-axis diameter ≤8 mm) in patients with PTC. Materials and Methods This single-center study prospectively enrolled consecutive participants with confirmed PTC and suspicious LNs at US from October 2020 to October 2021. All participants underwent CEUS, 1 week before biopsy or surgery, with intravenous perfluorobutane contrast material to visualize the LNs in the vascular phase (5-60 seconds after injection) and postvascular phase (10-30 minutes after injection). The reference standard was cytologic and surgical histologic assessment of the LNs. The sensitivity, specificity, positive predictive value, negative predictive value, and accuracy of sonographic features were calculated, and the diagnostic performance of US, CEUS, and the combination of postvascular phase and US features was assessed using multivariable logistic regression models. Results A total of 135 participants (median age, 36 years [IQR, 30-46 years]; 100 women) with 161 suspicious LNs at US were evaluated, including 67 metastatic and 94 benign LNs. The specificity of perfusion defect as a sonographic feature in the vascular phase reached 96% (90 of 94 LNs), and the negative predictive value of non-isoenhancement (ie, hypoenhancement, partial enhancement, and no enhancement) in the postvascular phase reached 100% (83 of 83 LNs). The area under the receiver operating characteristic curve (AUC) of the combination of postvascular phase and US features was 0.94 (95% CI: 0.89, 0.97), significantly higher than that of US features alone (AUC, 0.73; 95% CI: 0.65, 0.79; P < .001). Conclusion The postvascular phase of CEUS with perfluorobutane demonstrated excellent performance for diagnosing suspicious small lateral cervical LNs in participants with PTC. Published under a CC BY 4.0 license Supplemental material is available for this article. See also the editorial by Gunabushanam in this issue.

UI MeSH Term Description Entries
D008198 Lymph Nodes They are oval or bean shaped bodies (1 - 30 mm in diameter) located along the lymphatic system. Lymph Node,Node, Lymph,Nodes, Lymph
D008207 Lymphatic Metastasis Transfer of a neoplasm from its primary site to lymph nodes or to distant parts of the body by way of the lymphatic system. Lymph Node Metastasis,Lymph Node Metastases,Lymphatic Metastases,Metastasis, Lymph Node
D002291 Carcinoma, Papillary A malignant neoplasm characterized by the formation of numerous, irregular, finger-like projections of fibrous stroma that is covered with a surface layer of neoplastic epithelial cells. (Stedman, 25th ed) Carcinomas, Papillary,Papillary Carcinoma,Papillary Carcinomas
D003287 Contrast Media Substances used to allow enhanced visualization of tissues. Radiopaque Media,Contrast Agent,Contrast Agents,Contrast Material,Contrast Materials,Radiocontrast Agent,Radiocontrast Agents,Radiocontrast Media,Agent, Contrast,Agent, Radiocontrast,Agents, Contrast,Agents, Radiocontrast,Material, Contrast,Materials, Contrast,Media, Contrast,Media, Radiocontrast,Media, Radiopaque
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000077273 Thyroid Cancer, Papillary An ADENOCARCINOMA that originates from follicular cells of the THYROID GLAND and accounts for the majority of THYROID CANCER cases. Cells exhibit enlarged, oval, or elongated morphologies with clear, round, nuclei. Fusions of RET, NTRK1, TPM3, and PCM1 genes are associated with this cancer. Familial Nonmedullary Thyroid Cancer,Nonmedullary Thyroid Carcinoma,Papillary Carcinoma Of Thyroid,Papillary Thyroid Carcinoma,Thyroid Carcinoma, Papillary,Cancer, Papillary Thyroid,Cancers, Papillary Thyroid,Carcinoma, Nonmedullary Thyroid,Carcinoma, Papillary Thyroid,Carcinomas, Nonmedullary Thyroid,Carcinomas, Papillary Thyroid,Nonmedullary Thyroid Carcinomas,Papillary Thyroid Cancer,Papillary Thyroid Cancers,Papillary Thyroid Carcinomas,Thyroid Cancers, Papillary,Thyroid Carcinoma, Nonmedullary,Thyroid Carcinomas, Nonmedullary,Thyroid Carcinomas, Papillary
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective
D013964 Thyroid Neoplasms Tumors or cancer of the THYROID GLAND. Cancer of Thyroid,Thyroid Cancer,Cancer of the Thyroid,Neoplasms, Thyroid,Thyroid Adenoma,Thyroid Carcinoma,Adenoma, Thyroid,Adenomas, Thyroid,Cancer, Thyroid,Cancers, Thyroid,Carcinoma, Thyroid,Carcinomas, Thyroid,Neoplasm, Thyroid,Thyroid Adenomas,Thyroid Cancers,Thyroid Carcinomas,Thyroid Neoplasm

Related Publications

Lingli Xiao, and Jianhua Zhou, and Wen Tan, and Ying Liu, and Haoming Zheng, and Guanying Wang, and Wei Zheng, and Xiaoqing Pei, and Ankui Yang, and Longzhong Liu
May 2023, Radiology,
Lingli Xiao, and Jianhua Zhou, and Wen Tan, and Ying Liu, and Haoming Zheng, and Guanying Wang, and Wei Zheng, and Xiaoqing Pei, and Ankui Yang, and Longzhong Liu
November 2019, Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico,
Lingli Xiao, and Jianhua Zhou, and Wen Tan, and Ying Liu, and Haoming Zheng, and Guanying Wang, and Wei Zheng, and Xiaoqing Pei, and Ankui Yang, and Longzhong Liu
February 2007, Growth factors (Chur, Switzerland),
Lingli Xiao, and Jianhua Zhou, and Wen Tan, and Ying Liu, and Haoming Zheng, and Guanying Wang, and Wei Zheng, and Xiaoqing Pei, and Ankui Yang, and Longzhong Liu
July 2011, Surgery,
Lingli Xiao, and Jianhua Zhou, and Wen Tan, and Ying Liu, and Haoming Zheng, and Guanying Wang, and Wei Zheng, and Xiaoqing Pei, and Ankui Yang, and Longzhong Liu
November 2017, Experimental and therapeutic medicine,
Lingli Xiao, and Jianhua Zhou, and Wen Tan, and Ying Liu, and Haoming Zheng, and Guanying Wang, and Wei Zheng, and Xiaoqing Pei, and Ankui Yang, and Longzhong Liu
April 2017, Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae,
Lingli Xiao, and Jianhua Zhou, and Wen Tan, and Ying Liu, and Haoming Zheng, and Guanying Wang, and Wei Zheng, and Xiaoqing Pei, and Ankui Yang, and Longzhong Liu
January 2015, Scientific reports,
Lingli Xiao, and Jianhua Zhou, and Wen Tan, and Ying Liu, and Haoming Zheng, and Guanying Wang, and Wei Zheng, and Xiaoqing Pei, and Ankui Yang, and Longzhong Liu
January 2022, Frontiers in endocrinology,
Lingli Xiao, and Jianhua Zhou, and Wen Tan, and Ying Liu, and Haoming Zheng, and Guanying Wang, and Wei Zheng, and Xiaoqing Pei, and Ankui Yang, and Longzhong Liu
May 2021, Deutsche medizinische Wochenschrift (1946),
Lingli Xiao, and Jianhua Zhou, and Wen Tan, and Ying Liu, and Haoming Zheng, and Guanying Wang, and Wei Zheng, and Xiaoqing Pei, and Ankui Yang, and Longzhong Liu
August 2022, Laryngo- rhino- otologie,
Copied contents to your clipboard!